Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Prostate adenocarcinoma

Prostate adenocarcinoma

Part of Cancer

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Prostate adenocarcinoma

42 trials tracked for Prostate adenocarcinoma: 8 in phase 3 or 4 and 2 with published results. The most-cited published study has 66 citations.

42Trials tracked
8Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 1 Phase 3 7 Phase 2 20 Phase 1 3 Other / NA 11
  1. Phase 3 68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer Completed · 66 cited
  2. Phase 3 Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer Completed · 39 cited
  3. Phase 4 Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain Completed
  4. Phase 3 68Ga-PSMA-11 PET in Patients With Prostate Cancer Completed
  5. Phase 3 Clinical Trials of Adjuvant Androgen Deprivation in Localized Prostate Cancer Completed
  6. Phase 3 Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer Completed
Show 36 more trials
  1. Phase 3 68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment Completed
  2. Phase 3 Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI Completed
  3. Phase 2 Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring Completed
  4. Phase 2 Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients Completed
  5. Phase 2 A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects Completed
  6. Phase 2 Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer Completed
  7. Phase 2 Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer Completed
  8. Phase 2 Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer Completed
  9. Phase 2 Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy Completed
  10. Phase 2 Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer Completed
  11. Phase 2 Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer Completed
  12. Phase 2 Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer Completed
  13. Phase 2 Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer Completed
  14. Phase 2 Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer Completed
  15. Phase 2 Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate Completed
  16. Phase 2 Tivantinib in Treating Patients With Metastatic Prostate Cancer Completed
  17. Phase 2 Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer Completed
  18. Phase 2 Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence Completed
  19. Phase 2 Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer Completed
  20. Phase 2 Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer Completed
  21. Phase 2 Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer Completed
  22. Phase 2 Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer Completed
  23. Phase 1 Cabozantinib (XL184) in Men With Castrate-Resistant Prostate Cancer Completed
  24. Phase 1 Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer Completed
  25. Phase 1 177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer Completed
  26. N/A Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study Completed
  27. N/A Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer Completed
  28. N/A Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203) Completed
  29. N/A Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial Completed
  30. N/A Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma Completed
  31. N/A CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer Completed
  32. N/A Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer Completed
  33. N/A PROState Pathway Embedded Comparative Trial Completed
  34. N/A Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation Completed
  35. N/A MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer Completed
  36. N/A Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy Completed

Showing the 42 most-cited and recently-updated of 42 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this condition. Check back soon.